OZANIMOD (Zeposia®)

Clinical Indication

For treating moderately to severely active ulcerative colitis

Comments

In line with NICE TA828

Implementation date 5th January 2023

Date of classification

December 2022

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.